Testing effectiveness (Phase 2)Study completedNCT01875718
What this trial is testing
A Phase I/II Study to Evaluate UC1010 Treatment in Premenstrual Dysphoric Disorder (PMDD)
Who this might be right for
Premenstrual Dysphoric Disorder
Umecrine Mood AB 146